The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

AmerisourceBergen Corp

NYSE: ABC
Last

(U.S.) $88.90

Today's change-0.42 -0.47%
Updated November 20 4:01 PM EST. Delayed by at least 15 minutes.
 

AmerisourceBergen Corp

NYSE: ABC
Last

(U.S.) $88.90

Today's change-0.42 -0.47%
Updated November 20 4:01 PM EST. Delayed by at least 15 minutes.

AmerisourceBergen Corp down (U.S.)$0.42

AmerisourceBergen Corp closed lower Thursday, dropping (U.S.)$0.42 or 0.47% to (U.S.)$88.90. Over the last five days, shares are unchanged, but are currently 1.19% below its 52-week high. This security has outperformed the S&P 500 by 12.97% during the last year.

Key company metrics

  • Open(U.S.) $89.19
  • Previous close(U.S.) $89.32
  • High(U.S.) $89.31
  • Low(U.S.) $88.34
  • Bid / Ask-- / --
  • YTD % change+26.44%
  • Volume1,411,695
  • Average volume (10-day)1,608,763
  • Average volume (1-month)2,199,627
  • Average volume (3-month)1,660,489
  • 52-week range(U.S.) $62.55 to (U.S.) $89.97
  • Beta0.65
  • Trailing P/E74.34×
  • P/E 1 year forward20.12×
  • Forward PEG1.58×
  • Indicated annual dividend(U.S.) $1.16
  • Dividend yield1.30%
  • Trailing EPS(U.S.) $1.20
Updated November 20 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.24%

Based on its net profit margin of 0.24%, AmerisourceBergen Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.63%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue31,58930,34828,45629,176
Total other revenue--------
Total revenue31,58930,34828,45629,176
Gross profit873695730688
Total cost of revenue30,71629,65427,72628,488
Total operating expense31,38130,27028,15529,017
Selling / general / administrative615533382480
Research & development--------
Depreciation / amortization50474444
Interest expense (income), net operating--------
Unusual expense (income)13734
Other operating expenses, total--------
Operating income20778301160
Interest income (expense), net non-operating---21-20-19
Gain (loss) on sale of assets--------
Other--------
Income before tax18858285141
Income after tax68-1318049
Income tax, total1207110592
Net income68-1318041
Total adjustments to net income--------
Net income before extra. items68-1318049
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items68-1318049
Inc. avail. to common incl. extra. items68-1318041
Diluted net income68-1318040
Dilution adjustment00---1
Diluted weighted average shares235226236237
Diluted EPS excluding extraordinary itemsvalue per share0.29-0.060.760.20
Dividends per sharevalue per share0.240.240.240.24
Diluted normalized EPSvalue per share0.290.050.770.21